Literature DB >> 16964543

HFE mutations analysis of Turkish patients with nonalcoholic steatohepatitis.

Halis Simsek, Yasemin H Balaban, Hale Sümer, Engin Yilmaz, Gonca Tatar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16964543     DOI： 10.1007/s10620-006-9114-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

1.  Insulin resistance-associated hepatic iron overload.

Authors:  M H Mendler; B Turlin; R Moirand; A M Jouanolle; T Sapey; D Guyader; J Y Le Gall; P Brissot; V David; Y Deugnier
Journal:  Gastroenterology       Date:  1999-11       Impact factor: 22.682

2.  Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis.

Authors:  Suleyman Uraz; Cem Aygun; Abdullah Sonsuz; Gulsen Ozbay
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

3.  Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

Authors:  D K George; S Goldwurm; G A MacDonald; L L Cowley; N I Walker; P J Ward; E C Jazwinska; L W Powell
Journal:  Gastroenterology       Date:  1998-02       Impact factor: 22.682

4.  Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations.

Authors:  Ajay Duseja; Reena Das; Mohit Nanda; Ashim Das; Gurjeewan Garewal; Yogesh Chawla
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

5.  Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.

Authors:  H L Bonkovsky; Q Jawaid; K Tortorelli; P LeClair; J Cobb; R W Lambrecht; B F Banner
Journal:  J Hepatol       Date:  1999-09       Impact factor: 25.083

6.  Mutations of the HFE gene among Turkish hereditary hemochromatosis patients.

Authors:  Halis Simsek; Yasemin H Balaban; Engin Yilmaz; Hale Sumer; Yahya Buyukasik; Cem Cengiz; Osman Ozcebe; Gulsen Hascelik; Gonca Tatar
Journal:  Ann Hematol       Date:  2005-05-04       Impact factor: 3.673

Review 7.  Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis.

Authors:  Shivakumar Chitturi; Jacob George
Journal:  Curr Gastroenterol Rep       Date:  2003-02

8.  Role of liver biopsy in the diagnosis of hepatic iron overload in the era of genetic testing.

Authors:  Shirin Nash; Sharon Marconi; Krystyna Sikorska; Rizwan Naeem; Gerald Nash
Journal:  Am J Clin Pathol       Date:  2002-07       Impact factor: 2.493

9.  Frequency of HFE mutations among Turkish blood donors according to transferrin saturation: genotype screening for hereditary hemochromatosis among voluntary blood donors in Turkey.

Authors:  Halis Simsek; Hale Sumer; Engin Yilmaz; Yasemin H Balaban; Osman Ozcebe; Gulsen Hascelik; Yahya Buyukask; Gonca Tatar
Journal:  J Clin Gastroenterol       Date:  2004-09       Impact factor: 3.062

10.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682
  10 in total
  3 in total

Review 1.  Hemochromatosis gene and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Ruben Hernaez; Edwina Yeung; Jeanne M Clark; Kris V Kowdley; Frederick L Brancati; Wen Hong Linda Kao
Journal:  J Hepatol       Date:  2011-02-24       Impact factor: 25.083

2.  In the presence of autoantibodies and iron overload, do not judge a book by its cover: A case report.

Authors:  Nur Yazdali Koylu; Bahadir Koylu; Cenk Sokmensuer; Yasemin Balaban
Journal:  Hepatol Forum       Date:  2021-05-24

3.  Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls.

Authors:  Qing Ye; Bao-Xin Qian; Wei-Li Yin; Feng-Mei Wang; Tao Han
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.